Skip to main content
Atrás
RAFLF logo

Raffles Medical Group Ltd

Calidad de datos: 100%
Sobrecompra
RAFLF
OTC Healthcare Medical - Care Facilities
$0.80
$0.00 (0.00%)
Cap. Mercado: 1.47B
Rango del Día
$0.72 $0.80
Rango de 52 Semanas
$0.60 $0.83
Volumen
3,000
Promedio 50D / 200D
$0.75 / $0.76
Cierre Anterior
$0.80

Historial de Precios

Tendencias Financieras

Comparación con Pares

vs mediana del sector Healthcare (627 pares)

Métrica Acción Mediana del Sector
P/E 20.9 0.3
P/B 1.4 2.9
ROE % 6.7 3.7
Net Margin % 9.2 3.8
Rev Growth 5Y % 1.4 10.0
D/E 0.1 0.2

Precio Objetivo de Analistas

No hay cobertura de analistas disponible

Estimaciones de Ganancias

Período EPS Est. Ingresos Est. Analistas
FY2028 $0.04
$0.04 – $0.04
 870 M 1
FY2027 $0.03
$0.03 – $0.03
 830 M 1
FY2026 $0.03
$0.03 – $0.03
 790 M 1

Puntos Clave

Revenue grew 1.38% annually over 5 years — modest growth
Debt/Equity of 0.11 — conservative balance sheet
Generating 98.04M in free cash flow
Cash machine — converts 139.03% of earnings into free cash flow
Capital efficient — spends only 1.03% of revenue on capex

Crecimiento

Revenue Growth (5Y)
1.38%
Revenue (1Y)1.75%
Earnings (1Y)13.29%
FCF Growth (3Y)-23.79%

Calidad

Return on Equity
6.69%
ROIC5.84%
Net Margin9.22%
Op. Margin11.93%

Seguridad

Debt / Equity
0.11
Current Ratio1.31
Interest Coverage22.30

Valoración

P/E Ratio
20.88
P/B Ratio1.39
EV/EBITDA13.98
Dividend Yield0.03%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 1.75% Revenue Growth (3Y) 3.93%
Earnings Growth (1Y) 13.29% Earnings Growth (3Y) -11.56%
Revenue Growth (5Y) 1.38% Earnings Growth (5Y) -4.33%
Profitability
Revenue (TTM) 764.73M Net Income (TTM) 70.52M
ROE 6.69% ROA 4.94%
Gross Margin 17.87% Operating Margin 11.93%
Net Margin 9.22% Free Cash Flow (TTM) 98.04M
ROIC 5.84% FCF Growth (3Y) -23.79%
Safety
Debt / Equity 0.11 Current Ratio 1.31
Interest Coverage 22.30 Dividend Yield 0.03%
Valuation
P/E Ratio 20.88 P/B Ratio 1.39
P/S Ratio 1.93 PEG Ratio 1.77
EV/EBITDA 13.98 Dividend Yield 0.03%
Market Cap 1.47B Enterprise Value 1.28B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 764.73M 751.56M 708.03M 822.92M 723.79M
Net Income 70.52M 62.24M 90.15M 143.21M 84.17M
EPS (Diluted) 0.04 0.03 0.05 0.08 0.04
Gross Profit 136.63M 486.14M 315.94M 639.98M 580.52M
Operating Income 91.27M 82.49M 115.76M 195.85M 121.31M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 1.43B 1.53B 1.53B 1.50B 1.55B
Total Liabilities 373.70M 465.82M 484.38M 467.30M 568.67M
Shareholders' Equity 1.06B 1.05B 1.03B 1.02B 960.79M
Total Debt 114.76M 88.17M 124.70M 96.14M 198.13M
Cash & Equivalents 310.56M 343.67M 343.60M 253.13M 264.99M
Current Assets 435.48M 516.32M 484.70M 494.35M 439.10M
Current Liabilities 333.33M 381.94M 379.38M 362.99M 416.61M